361 related articles for article (PubMed ID: 23590310)
21. Deletion of the sequence encoding the tail domain of the bone morphogenetic protein type 2 receptor reveals a bone morphogenetic protein 7-specific gain of function.
Leyton PA; Beppu H; Pappas A; Martyn TM; Derwall M; Baron DM; Galdos R; Bloch DB; Bloch KD
PLoS One; 2013; 8(10):e76947. PubMed ID: 24116187
[TBL] [Abstract][Full Text] [Related]
22. Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance.
Flynn C; Zheng S; Yan L; Hedges L; Womack B; Fessel J; Cogan J; Austin E; Loyd J; West J; Zhao Z; Hamid R
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):20-7. PubMed ID: 22312021
[TBL] [Abstract][Full Text] [Related]
23. Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis.
Sermet-Gaudelus I; Boeck KD; Casimir GJ; Vermeulen F; Leal T; Mogenet A; Roussel D; Fritsch J; Hanssens L; Hirawat S; Miller NL; Constantine S; Reha A; Ajayi T; Elfring GL; Miller LL
Am J Respir Crit Care Med; 2010 Nov; 182(10):1262-72. PubMed ID: 20622033
[TBL] [Abstract][Full Text] [Related]
24. Network of MicroRNAs Mediate Translational Repression of Bone Morphogenetic Protein Receptor-2: Involvement in HIV-Associated Pulmonary Vascular Remodeling.
Chinnappan M; Mohan A; Agarwal S; Dalvi P; Dhillon NK
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478969
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.
Upton PD; Davies RJ; Tajsic T; Morrell NW
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1135-45. PubMed ID: 23937428
[TBL] [Abstract][Full Text] [Related]
26. Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelial Growth Factor Receptor 3 in Pulmonary Arterial Hypertension.
Hwangbo C; Lee HW; Kang H; Ju H; Wiley DS; Papangeli I; Han J; Kim JD; Dunworth WP; Hu X; Lee S; El-Hely O; Sofer A; Pak B; Peterson L; Comhair S; Hwang EM; Park JY; Thomas JL; Bautch VL; Erzurum SC; Chun HJ; Jin SW
Circulation; 2017 Jun; 135(23):2288-2298. PubMed ID: 28356442
[TBL] [Abstract][Full Text] [Related]
27. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.
Awad KS; Elinoff JM; Wang S; Gairhe S; Ferreyra GA; Cai R; Sun J; Solomon MA; Danner RL
Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(2):L187-201. PubMed ID: 26589479
[TBL] [Abstract][Full Text] [Related]
28. Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension.
Nasim MT; Ghouri A; Patel B; James V; Rudarakanchana N; Morrell NW; Trembath RC
Hum Mol Genet; 2008 Jun; 17(11):1683-94. PubMed ID: 18321866
[TBL] [Abstract][Full Text] [Related]
29. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
Yu PB; Beppu H; Kawai N; Li E; Bloch KD
J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158
[TBL] [Abstract][Full Text] [Related]
30. A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension.
Shintani M; Yagi H; Nakayama T; Saji T; Matsuoka R
J Med Genet; 2009 May; 46(5):331-7. PubMed ID: 19211612
[TBL] [Abstract][Full Text] [Related]
31. Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.
Prewitt AR; Ghose S; Frump AL; Datta A; Austin ED; Kenworthy AK; de Caestecker MP
J Biol Chem; 2015 Jan; 290(2):960-71. PubMed ID: 25411245
[TBL] [Abstract][Full Text] [Related]
32. Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension.
Nakamura K; Sakaguchi M; Matsubara H; Akagi S; Sarashina T; Ejiri K; Akazawa K; Kondo M; Nakagawa K; Yoshida M; Miyoshi T; Ogo T; Oto T; Toyooka S; Higashimoto Y; Fukami K; Ito H
PLoS One; 2018; 13(9):e0203046. PubMed ID: 30180189
[TBL] [Abstract][Full Text] [Related]
33. Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.
West JD; Carrier EJ; Bloodworth NC; Schroer AK; Chen P; Ryzhova LM; Gladson S; Shay S; Hutcheson JD; Merryman WD
PLoS One; 2016; 11(2):e0148657. PubMed ID: 26863209
[TBL] [Abstract][Full Text] [Related]
34. Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension.
Wang L; Moonen JR; Cao A; Isobe S; Li CG; Tojais NF; Taylor S; Marciano DP; Chen PI; Gu M; Li D; Harper RL; El-Bizri N; Kim YM; Stankunas K; Rabinovitch M
Circ Res; 2023 Mar; 132(5):545-564. PubMed ID: 36744494
[TBL] [Abstract][Full Text] [Related]
35. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
[TBL] [Abstract][Full Text] [Related]
36. Crosstalk between BMP signaling and KCNK3 in phenotypic switching of pulmonary vascular smooth muscle cells.
Yeo Y; Jeong H; Kim M; Choi Y; Kim KL; Suh W
BMB Rep; 2022 Nov; 55(11):565-570. PubMed ID: 36016502
[TBL] [Abstract][Full Text] [Related]
37. Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension.
Nasim MT; Ogo T; Ahmed M; Randall R; Chowdhury HM; Snape KM; Bradshaw TY; Southgate L; Lee GJ; Jackson I; Lord GM; Gibbs JS; Wilkins MR; Ohta-Ogo K; Nakamura K; Girerd B; Coulet F; Soubrier F; Humbert M; Morrell NW; Trembath RC; Machado RD
Hum Mutat; 2011 Dec; 32(12):1385-9. PubMed ID: 21898662
[TBL] [Abstract][Full Text] [Related]
38. Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle.
Hagen M; Fagan K; Steudel W; Carr M; Lane K; Rodman DM; West J
Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1473-9. PubMed ID: 17322283
[TBL] [Abstract][Full Text] [Related]
39. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
[TBL] [Abstract][Full Text] [Related]
40. Transcripts from a novel BMPR2 termination mutation escape nonsense mediated decay by downstream translation re-initiation: implications for treating pulmonary hypertension.
Hamid R; Hedges LK; Austin E; Phillips JA; Loyd JE; Cogan JD
Clin Genet; 2010 Mar; 77(3):280-6. PubMed ID: 20095988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
